Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLiSS: Multilevel Tobacco Intervention for Underserved Families
NCT02602288Completed
- Sponsor
- Temple University
- Start
- Feb 2016
- Primary completion
- Oct 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine polacrilex in nicotine dependence (2 arms), sponsored by Temple University. Primary endpoints: Child Urine Cotinine at 12 months and Cigarettes per Day at 12 months. Started Feb 2016; status: completed.
02
Drugs
nicotine polacrilex
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02602288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602288.